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Background: Van der Woude syndrome is the most common among syndromes which include cleft lip and/or
cleft palate as one of the presentations. It is usually caused by mutations in the interferon regulatory factor 6 (IRF6)
gene.
Case presentation: We previously reported on a patient with suspected deletion of the IRF6 gene. Using the
Affymetrix Human SNP 6.0 Array, the interstitial deletion has been confirmed and found to be approximately
2.327–2.334 Mb within the 1q32.2 region. Although several known genes were deleted, the patient has no other
phenotype apart from the orofacial presentations typical of VWS. The same deletion was not present in either
parent and his two siblings were also phenotypically normal.
Conclusions: Other than IRF6, the genes which are deleted in this patient appear to be insensitive to copy number
and haploinsufficiency. We compared the deletion in this patient with another case which was also mapped by
high resolution array but had additional phenotypic features.
Keywords: 1q32, IRF6 gene, Microdeletion, Orofacial clefting, SNP array, Syndromic clefting, Van der Woude
syndromeBackground
Cleft lip and/or cleft palate are common congenital birth
defects which can occur in isolation or as part of a syn-
dromic disorder. Among the more than 300 syndromes
with orofacial clefting as one of the associated features,
Van der Woude syndrome (VWS; MIM #119300) is the
most common, accounting for approximately 2% of all
cases. Except for the presence of paramedian lower lip
pits and hypodontia, the presentation closely resembles
that of isolated cleft lip and/or cleft palate. The inherit-
ance pattern is autosomal dominant with the frequency
at approximately one in 35,000 –100,000.
In 2002, the gene involved in VWS was identified as
that encoding the interferon regulatory factor 6 (IRF6), a
member of the interferon regulatory factor family of
transcription factors [1]. The study identified 46 muta-
tions in IRF6 in patients with VWS and another 13 in* Correspondence: tanec@bigfoot.com
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reproduction in any medium, provided the orpatients with popliteal pterygium syndrome (PPS; MIM
119500). The PPS phenotype includes other congenital
anomalies such as webbing of the skin, bifid scrotum,
syndactyly of the fingers or toes in addition to orofacial
clefting.
The two different syndromic disorders are caused by
mutations in the same gene but the resulting phenotype
depends on the exact nucleotide or amino acid involved
and the position of the mutation. The mechanism is sug-
gested to be haploinsufficiency for VWS and dominant-
negative for PPS [1]. Most of the identified mutations in
VWS are nonsense and missense mutations found in
exons which encode the DNA-binding or protein-
binding domains. In the case of PPS, except for one
nonsense mutation (Q393X), the rest involve substitu-
tions of amino acid residues in the DNA-binding
domain which makes direct contact with DNA. In vitro
binding assays with the IRF6 protein showed that the 12
of the 13 mutations identified in VWS/PPS patients and
mapped within the DNA-binding domain inhibited
DNA binding. For mutations within the protein-binding
region, six out of seven inhibited transcriptional activation. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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effect [2].
Mutations in IRF6 have been identified in VWS pa-
tients from different ethnic groups. Most cases of VWS
are inherited. Although penetrance is incomplete, it is
still high at approximately 92%. Sequence analysis of the
IRF6 coding region (exons 1–9) can detect mutations in
70% of patients with the VWS phenotype, of which 80%
of the mutations would be within the protein-codingFigure 1 Results from analysis with Affymetrix SNP 6.0 array viewed w
on 1q32.2 for the patient with VWS. (B) Analysis of the father’s genome for
1q32.2 region.exons 3–9. In less than 2% of individuals with VWS, the
entire IRF6 gene is deleted [3].
We previously described a case of de novo deletion as
observed by the loss of paternal alleles and complete
homozygosity of IRF6 gene polymorphisms. The re-
duced gene dosage was confirmed by MLPA [4]. In this
paper, we described the mapping of the deletion in this
patient using a high resolution single nucleotide poly-
morphism (SNP) array.ith Chromosome Analysis Suite. (A) Copy number loss for probes
the 1q32.2 region. (C) Analysis of the mother’s genome for the
Table 1 Genes and microRNAs in the region deleted in







Yes CR1L CR-1 like 3b/4b binding protein 89
Yes CD46* CD46 antigen, complement regulatory
protein
79
No AK123177 Homo sapiens cDNA FLJ41182 fis,
clone BRACE2043349
-
- MIR29C microRNA29C -
- MIR29B2 MIR29B2 microRNAB2 -
No LOC148696 Hypothetical gene – non-coding RNA -
Yes CD34 CD34 antigen isoform b 96
Yes PLXNA2 Plexin A2 26
No ATP5G2P1 Hypothetical protein LOC642587 -




Yes LAMB3* Laminin, beta 3 precursor 79
- MIR4260 MicroRNA 4260 -
Yes G0S2 G0/G1switch 2 78
Yes HSD11B1* 11-beta-hydroxysteroid dehydrogenase
1
28
Yes TRAF3IP3 TRAF3-interacting JNK-activating
modulator
42
No C1orf74 Chromosome 1 open reading frame
74; hypothetical protein LOC148304
68
Yes IRF6* Interferon regulatory factor 6 8
No DIEXF C1orf107; (digestive-organ expansion
factor homolog)
30
Yes SYT14* Synaptotagmin XIV 65
No C1orf 133 SERTAD4 antisense RNA 1
(SERTAD4-AS1)
-
No SERTAD4 SERTA domain containing 4 60
Yes HHAT Hedgehog acyltransferase 78
Yes KCNH1 Potassium voltage-gated channel,
subfamily H (eag-related), member 1
16
No CR621662 Full-length cDNA clone CS0DJ006YN03
of T cells
-
No RCOR3 REST corepressor 3 isoform d 16
No KIAA1343 Homo sapiens mRNA for KIAA1343
protein, partial cds
-
Yes TRAF5 TNF receptor-associated factor 5 86
No BC005997 Homo sapiens cDNA FLJ27347 -
No LINC00467 C1orf97;Homo sapiens long intergenic
non-protein coding RNA 467
94
Yes RD3* Retinal degeneration 3 39
Yes SLC30A1 Solute carrier family 30
(zinc transporter) member 1
23
No CR605189 Full-length cDNA clone CS0DK012YI08
of HeLa cells
-
Yes NEK2 NIMA-related kinase 2 5
Table 1 Genes and microRNAs in the region deleted in





Yes INTS7 Integrator complex subunit 7 23
Yes DTL Denticleless homolog 9
- MIR3122 Homo sapiens microRNA 3122 -
Yes PPP2R5A Protein phosphatase 2, regulatory
subunit B
10
No FKSG56 Homo sapiens FKSG56 (FKSG56) mRNA -
No SNORA16B Homo sapiens small nucleolar RNA,
H/ACA box 16B
-
No TMEM206 Transmembrane protein 206 78
Yes NENF Neuron derived neurotrophic factor
precursor
68
*OMIM morbid genes classified as Disease-causing as displayed on UCSC
Genome Browser [5].
+From DECIPHER database [6].
The deletion for the patient in this report is from CR1L to SYT14 while the
deletion for the patient in Salahshourifar et al. is from CAMK1G to NENF.
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The patient is the eldest of three children of healthy
unrelated parents of Chinese ancestry. There was no sig-
nificant family history of cleft lip and palate. He was pre-
viously found to have features consistent with Van der
Woude Syndrome due to the presence of cleft lip and
palate and lower lip pits.
DNA was extracted from frozen whole blood samples
using the Gentra Puregene Blood Kit (Gentra Systems Inc.,
Minneapolis, USA). It was checked for quantity and purity
using the NanoDrop Spectrophotometer (NanoDrop Tech-
nologies, Wilmington, USA). Genome-wide Human SNP
6.0 Array (Affymetrix Inc., Santa Clara, USA) containing
more than 906,600 SNPs and more than 946,600 copy
number probes was used. Labeling, hybridization, washing,
scanning and image extraction were performed by an
Affymetrix certified service laboratory according to manu-
facturer’s instructions. Data was analyzed using Chromo-
some Analysis Suite.
Based on the analysis results for all chromosomes,
there was a copy number loss in 1q32 from at least pos-
ition 205,941,798 to position 208,274,440 (NCBI36/hg18
or 207,875,175−210,207,817 for GR37/hg19). The size is
at least 2,332 kb involving 1,894 markers (1,113 SNP
and 781 CNV markers) (Figure 1A). The last SNP with
normal copy number is rs1830762 (genotype called as
“GA”) at position 205,940,895. The first SNP with al-
tered copy number is rs4844614 (genotype called as
“GG”) at position 205,942,060. The last SNP with altered
copy number is rs227193 (genotype called as “AA”) at
position 208,279,047. The first SNP with normal copy
Table 2 Summary of VWS cases with deletion ≥ 1 Mb
Case reference Family history Size Additional phenotpye Developmental delay
Bocian & Walker [10] No Microscopic Facial dysmorphism, skeletal abnormality, hypotonia Yes
VWS1473 [7,11] Yes ~ 1 Mb Other disabilities* Yes
VWS771 [7] Yes 1–2 Mb None reported No
Salahshourifar et al. [12] No ~2.98 Mb Dysmorphism, growth retardation No
This report No ~2.33 Mb None No
*family members were reported as having slow perceptive faculty, one died for unknown reasons, another incapable of speech.
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position 208,282,037. The proximal breakpoint is within
Variation_3328, while the distal breakpoint is between
varation_34766 and variation_9388 and within intron 4
of the synaptotagmin 14 (SYT14) trafficking gene. Both
parental samples were also tested in the same experi-
ment on different arrays. There was no similar deletion
in either parent (Figures 1B and C).
Information obtained from the online databases showed
that nine annotated genes (including IRF6) were com-
pletely deleted and two more were partially deleted. There
were several more hypothetical genes and microRNAs
(Table 1). Besides the identified genes, there are other se-
quences with open reading frames and hypothetical pro-
teins within the deleted region such as LOC729533
(FAM72A), LOC440712 (C1 orf186), HCA56, C1orf116,
pfkfb2, YOD1, AXX229788, EU154352, LOC148696, AK
123177, KIAA0463, LOC642587, DM004461, LOC148304
(C1 orf74) and C1 orf107.
Discussion
The VWS locus was first mapped to the chromosomal
region 1q32-41 [7] before mutations in the IRF6 gene
were identified in patients with VWS and PPS [1]. Al-
though SNPs in the gene have been associated with
non-syndromic cleft lip and/or cleft palate [8], no other
syndrome has been linked to the gene. While most
identified mutations in VWS families were single nu-
cleotide substitutions, there are a few cases of deletions.
Most of the latter were small within-gene deletions
which ranged from 5 to18 bp [1]. There was one reportFigure 2 Genomic map of the 1q32 region viewed using Integrative G
the approximate breakpoint positions for the four reported deletions in VWof a 17-kb deletion involving exons 4–9 in a Japanese
family [9].
There is no recognized microdeletion syndrome for
this chromosomal region, indicating that pathogenic
genomic imbalance in this region is rare. For larger dele-
tions which include additional genes outside of the IRF6
genomic region, there are only four previous reports
(Table 2): a Mexican girl with cytogenetically visible de-
letion from 1q32-41 [10], submicroscopic deletions in
two families VWS1473 and VWS771 [7,11], and a Malay
girl whose deletion was mapped by oligonucleotide-based
comparative genomic hybridization (CGH) [12]. The
patient in this report will be only the fifth case in the
series (Table 2). A CGH study using BAC arrays detected
microdeletions involving 1q32.2 in five cases (including
VWS1473 and VWS771) but no information was provided
on the size and breakpoints for each case [13].
In the present case, the breakpoint for the proximal
end of the deletion is within a segment known as
variation_3328 which is a copy number polymorphism
(CNV). The distal breakpoint is within a large intron of
the STY14 gene. Some of the genes in the deleted region
are associated with conditions listed in Online Mendelian
Inheritance in Men (OMIM). They are CR1L with SLE
susceptibility, CD46 with measles, LAMB3 with epider-
molysis bullosa (OMIM #226650 and 226700), and
HSD11B1 with cortisone reductase deficiency. However,
this patient has no other clinically significant pathology.
There is no psychomotor delay or intellectual disability
commonly found in patients with microdeletions involving
multiple genes, therefore it appears that the other deletedenome Viewer (IGV). Deleted region for each case is indicated with
S cases.
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this is consistent with the scores for Hapoinsufficiency
Index (HI) according to the DECIPHER database [6].
The IRF6 gene which has the most significant HI index
is also the only gene which could be linked to the pa-
tient’s phenotype.
For the four previously reported VWS families/cases
with deletions, the extent of the deletion in the case with
microscopic deletion is unknown (Case 1 in Table 2).
The other three deletions have been mapped by molecu-
lar methods. The distal breakpoint in VWS1473 and
VWS771 (Case 2 and Case 3 in Table 2) appeared to be
within the SYT14 gene, similar to that found in the
present case (Figure 2). However, the proximal break-
point is different for the three cases, with the present
case having the largest deletion extending beyond
D1S245 at the proximal end of the chromosome. This
marker was not deleted in the other two families
VWS1473 and VWS771. The deletion in the 22-month-old
Malay girl (Case 4 in Table 2) did not share similar
breakpoints at either end with any of the documented
cases. The deletion started at a more telomeric position
and extended further towards the telomere. Interestingly, it
was also a de novo occurrence on the paternal chromo-
some as in the present case [4,12]. For family VWS1473,
the deletion was on the maternally derived chromosome as
the maternal allele was missing for D1S3753 [7].
Developmental delay and dysmorphism was reported
for Case 1. Family VWS 1473 (Case 2) involved affected
members over three generations [11]. This is the only
family with developmental and psychomotor delay out
of over 300 VWS families studied. Along with cleft lip/
palate and lip pits, all affected relatives exhibited various
forms of developmental delay. There is one other report
of a child with VWS features and also presenting with
mental retardation but there was no karyotype informa-
tion [14]. Segregation of the VWS phenotype with intel-
lectual disability in these three instances suggests that
there is a gene involved in cognitive development in the
region, and it is due to a dominant mutation and not
haploinsufficiency. The 2.3 Mb microdeletion in our pa-
tient is bigger than that found in VWS1473 (Case 2 in
Table 2) but he has normal intelligence. He has been
followed up closely for the last 20 years and there is no
evidence of other clinically significant condition. The
loss of so many genes with no additional phenotypic
consequence other than VWS at birth is surprising but
is consistent with studies showing that the other genes
deleted are unlikely to be haploinsufficient.
The largest deletion reported thus far is 2.98 Mb (Case
4 in Table 2) detected using an Agilent 400 K CGH array
[12]. At the time of the report, the 22-month old child
was meeting developmental milestones with no evidence
of developmental delay. There were dysmorphic features(including syndactyly also seen in PPS) and some indica-
tion of growth retardation. This deletion is distinct from
others in that both proximal and distal breakpoints are
different from previously reported cases. The only deleted
genes shared are CAMK1G, G0S2, TRAF31P3, and IRF6.
The distal end extends much further and includes at least
10 more genes, three of which had Haploinsufficiency
Index (HI index) of less than 10, indicating that they are
dosage sensitive and expected to have phenotypic effect
(Table 1). However, none of the three genes have been
linked to the dysmorphic features observed in this patient.
Interestingly, the Development Disorder Genotype-
Phenotype Database (DDG2P) lists IRF6 as one of the
genes associated with developmental disorders [15]. It is
the only gene within the deleted which is listed as
having evidence of developmental delay in multiple
cases. However, there is no evidence of developmental
delay for both our patient and the patient with the
2.98 Mb deletion.
Conclusions
The deletion in our patient appeared to be a very rare
event with only two other de novo cases reported. Our
data suggest that other than IRF6, the genes that were
deleted were not affected by haploinsufficiency.
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